ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,653Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 780

$828K Total Retail Price of All Prescriptions

Rank: 115 out of 780

859 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 859 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 859 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 15,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 816 600 S3 1 1
LEVOTHYROXINE SODIUM 761 659 2 5
AMLODIPINE BESYLATE 597 542 3 4
OMEPRAZOLE 536 436 4 3
SIMVASTATIN 450 393 5 2
POTASSIUM CHLORIDE 438 363 6 11
TORSEMIDE 348 306 7 114
GABAPENTIN 331 215 8 13
CARVEDILOL 326 273 9 14
NEXIUM 316 237 10 22
ENALAPRIL MALEATE 301 265 11 64
METOPROLOL SUCCINATE 286 227 12 20
GLIMEPIRIDE 280 233 13 30
ZOLPIDEM TARTRATE 261 154 14 17
RANITIDINE HCL 260 195 15 39
FUROSEMIDE 255 227 16 7
METOPROLOL TARTRATE 242 221 17 19
LISINOPRIL 219 189 18 6
PRAVASTATIN SODIUM 215 193 19 9
AMIODARONE HCL 214 208 20 139
METFORMIN HCL ER 214 153 20 43
METHYLPREDNISOLONE 213 158 22 92
SERTRALINE HCL 191 173 23 27
HYDROCHLOROTHIAZIDE 163 126 24 10
AZITHROMYCIN 162 118 25 38
CLOPIDOGREL 162 135 25 34
TRAMADOL HCL 152 142 27 15
MELOXICAM 151 111 28 16
PEG 3350-ELECTROLYTE 149 95 29 324
DONEPEZIL HCL 148 148 30 31
METFORMIN HCL 148 103 30 8
CLONIDINE HCL 147 118 32 28
SYNTHROID 146 146 33 77
NAMENDA 142 136 34 46
PLAVIX 130 109 35 45
TAMSULOSIN HCL 127 106 36 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 82 37 26
ATORVASTATIN CALCIUM 122 122 38 12
ALLOPURINOL 121 109 39 29
SINGULAIR 117 86 40 73
ESCITALOPRAM OXALATE 117 90 40 61
PAROXETINE HCL 116 90 42 69
CITALOPRAM HBR 111 73 43 23
AMITRIPTYLINE HCL 110 94 R 44 48
DIOVAN HCT 109 102 45 75
VERAPAMIL ER 108 81 46 78
ROPINIROLE HCL 107 79 47 87
WARFARIN SODIUM 107 106 47 24
LOVAZA 105 96 49 183
LOSARTAN-HYDROCHLOROTHIAZIDE 105 91 49 33
ATENOLOL 103 77 51 21
ISOSORBIDE MONONITRATE ER 103 103 51 60
MIRTAZAPINE 97 95 53 58
LYRICA 97 64 53 52
DIGOXIN 96 72 55 56
FENTANYL 96 73 S2 55 107
CRESTOR 92 72 57 32
TIZANIDINE HCL 91 19 58 82
FLUTICASONE PROPIONATE 89 62 59 41
LABETALOL HCL 87 78 60 159
MONTELUKAST SODIUM 87 63 60 120
LOSARTAN POTASSIUM 86 72 62 18
CYMBALTA 84 24 63 51
FAMOTIDINE 83 62 64 86
PREDNISONE 81 80 65 40
PHENYTOIN SODIUM EXTENDED 81 70 65 128
DIOVAN 81 71 65 55
CIPROFLOXACIN HCL 79 63 68 49
RISPERIDONE 73 73 69 98
ADVAIR DISKUS 72 52 70 68
NYSTATIN 72 65 70 203
CALCITONIN-SALMON 71 71 72 362
LANTUS SOLOSTAR 71 55 72 121
LANTUS 70 69 74 71
ESTRADIOL 70 13 R 74 122
SUCRALFATE 67 53 76 149
NADOLOL 66 44 77 253
LOVASTATIN 64 52 78 47
METHOTREXATE 64 57 78 252
CELEBREX 59 46 80 89
CEPHALEXIN 59 49 80 105
LEVOFLOXACIN 59 43 80 76
BENAZEPRIL HCL 59 59 80 59
DOXEPIN HCL 58 45 84 170
CREON 57 51 85 424
PEN NEEDLE 57 47 85 136
BYSTOLIC 56 55 87 118
EVISTA 55 55 88 151
MECLIZINE HCL 54 51 89 83
ZENPEP 54 39 89 432
LANSOPRAZOLE 53 27 91 184
CLOTRIMAZOLE-BETAMETHASONE 51 48 92 166
TERAZOSIN HCL 51 48 92 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.